William Arsani

CIK 00018483721 companyCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001848372

Recent Transactions

20 trades

Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2025-08-13$5.25/sh−217,627→ 1,000,000 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2025-08-13$5.25/sh−345,000→ 2,655,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2025-06-10+19,000→ 19,000 total
Sale
Design Therapeutics, Inc.$DSGN
Common Stock
2024-08-09$4.25/sh−814,874→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2024-06-13+19,000→ 19,000 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2023-08-29$2.44/sh+1,960,000→ 3,000,000 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2023-08-28$2.15/sh+275,000→ 1,040,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-05-31+15,000→ 15,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2022-06-15+15,000→ 15,000 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-03-21$18.99/sh+25,000→ 2,797,501 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-08-31$15.45/sh+40,000→ 2,772,501 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30$20.00/sh+700,000→ 2,732,501 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+1,217,627→ 1,217,627 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+814,874→ 2,032,501 total
Conversion
Design Therapeutics, Inc.$DSGN
Series B Preferred Stock
2021-03-30−1,328,245→ 0 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+814,874→ 814,874 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+1,217,627→ 1,217,627 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30$20.00/sh+700,000→ 700,000 total
Conversion
Design Therapeutics, Inc.$DSGN
Series B Preferred Stock
2021-03-30−1,984,733→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2021-03-25+15,000→ 15,000 total

Companies

Design Therapeutics, Inc.
Director
$DSGN

Recent Filings

Address

C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110

CARLSBAD, CA, 92011

View on SEC.gov